(Q38636708)

5 September 2017

title

Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer (English)

1 reference

5 September 2017

1 reference

9

1 reference

5 September 2017

2

T K Kilvaer

1 reference

5 September 2017

8

O T Brustugun

1 reference

5 September 2017

11

S Solberg

1 reference

5 September 2017

T Donnem

1

1 reference

5 September 2017

S Andersen

3

1 reference

5 September 2017

E Richardsen

4

1 reference

5 September 2017

E E Paulsen

5

1 reference

5 September 2017

S M Hald

6

1 reference

5 September 2017

S Al-Saad

7

1 reference

5 September 2017

M Lund-Iversen

10

1 reference

5 September 2017

B H Gronberg

12

1 reference

5 September 2017

S G F Wahl

13

1 reference

5 September 2017

L Helgeland

14

1 reference

5 September 2017

O Fløtten

15

1 reference

5 September 2017

M Pohl

16

1 reference

5 September 2017

K Al-Shibli

17

1 reference

5 September 2017

T M Sandanger

18

1 reference

5 September 2017

F Pezzella

19

1 reference

5 September 2017

L T Busund

20

1 reference

5 September 2017

R M Bremnes

21

1 reference

5 September 2017

publication date

16 November 2015

1 reference

5 September 2017

1 reference

5 September 2017

volume

27

1 reference

5 September 2017

issue

2

1 reference

5 September 2017

page(s)

225-232

1 reference

5 September 2017

cites work

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Years of life lost as a measure of cancer burden on a national level

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Cancer classification using the Immunoscore: a worldwide task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Objective measurement and clinical significance of TILs in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Increased levels of tumor-infiltrating lymphocytes are associated with improved recurrence-free survival in stage 1A non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

The Treg/Th17 paradigm in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

Tissue microarray technology for high-throughput molecular profiling of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV560

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDV560

1 reference

release_jbpl2ymn3bhkfnsiu5khldpnvy

5 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jbpl2ymn3bhkfnsiu5khldpnvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference